Assuming that the recoveriX therapy achieves an average annual turnover of € 200,000 per system due to high patient demand – supported by targeted marketing measures to increase awareness and patient acquisition – then it represents a profitable source of income. The turnover-based franchise fee of 11% is fairly calculated and enables long-term success. The more patients you treat, the higher your earnings.